Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

Abstract:

:In landmark clinical trials, pharmacological inhibition of the renin-angiotensin system (RAS) with angiotensin-converting enzyme inhibitors (ACEIs) attenuated the decline in renal function associated with chronic renal disease (CRD). Hemodynamic and nonhemodynamic effects of angiotensin II (Ang II) attest to its central role in the pathogenesis of CRD. Angiotensin II subtype 1 receptor antagonists (AT1RA) differ from ACEI in their effects on the RAS and on bradykinin metabolism. Elevations in bradykinin levels associated with ACEI and stimulation of angiotensin subtype 2 receptors resulting from AT1RA may produce therapeutic effects unique to each class of drug. Nevertheless, in animal models of CRD, ACEI and AT1RA exert equivalent renoprotection, implying that their renoprotective effects result primarily from inhibition of Ang II-mediated stimulation of angiotensin subtype 1 receptors. Clinical data comparing ACEI and AT1RA therapy in renal disease are limited to short-term studies, which indicate that AT1RAs have equivalent effects to ACEI on the major determinants of CRD progression, namely blood pressure and proteinuria. AT1RAs were well tolerated, with side-effect profiles similar to placebo. Taken together, available evidence suggests that AT1RAs will share the renoprotective properties of ACEI in human CRD. Nevertheless, the results of long-term clinical trials are required before AT1RA can be recommended as an alternative to ACEI in renoprotective therapy.

journal_name

Kidney Int

journal_title

Kidney international

authors

Taal MW,Brenner BM

doi

10.1046/j.1523-1755.2000.00031.x

subject

Has Abstract

pub_date

2000-05-01 00:00:00

pages

1803-17

issue

5

eissn

0085-2538

issn

1523-1755

pii

S0085-2538(15)46933-9

journal_volume

57

pub_type

杂志文章,评审
  • L-Arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats.

    abstract:BACKGROUND:Ischemic acute renal failure (iARF) is associated with increased nitric oxide (NO) production during the reperfusion period, as endothelial nitric oxide synthase (eNOS) is maximally activated, and renal tubular inducible NOS (iNOS) is stimulated. Increased NO production leads to augmented tubular injury, pro...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2002.t01-1-00622.x

    authors: Schwartz IF,Schwartz D,Traskonov M,Chernichovsky T,Wollman Y,Gnessin E,Topilsky I,Levo Y,Iaina A

    更新日期:2002-11-01 00:00:00

  • The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3.

    abstract::The structure of the duodenal mucosa was evaluated in duodenal biopsy samples obtained from patients with moderate renal failure (MRF) and in dialysis patients (HD) in an effort to examine the possibility that changes in duodenal mucosa may contribute to the impaired calcium absorption in renal failure (RF). The effec...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1981.23

    authors: Goldstein DA,Horowitz RE,Petit S,Haldimann B,Massry SG

    更新日期:1981-02-01 00:00:00

  • mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

    abstract::Mitochondrial diseases represent a significant clinical challenge. Substantial efforts have been devoted to identifying therapeutic strategies for mitochondrial disorders, but effective interventions have remained elusive. Recently, we reported attenuation of disease in a mouse model of the human mitochondrial disease...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1016/j.kint.2018.08.038

    authors: Johnson SC,Martinez F,Bitto A,Gonzalez B,Tazaerslan C,Cohen C,Delaval L,Timsit J,Knebelmann B,Terzi F,Mahal T,Zhu Y,Morgan PG,Sedensky MM,Kaeberlein M,Legendre C,Suh Y,Canaud G

    更新日期:2019-02-01 00:00:00

  • A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.

    abstract::Genetic variation at the MYH9 locus is linked to the high incidence of focal segmental glomerulosclerosis (FSGS) and non-diabetic end-stage renal disease among African Americans. To further define risk alleles with FSGS we performed a genome-wide association analysis using more than one million single-nucleotide polym...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2010.251

    authors: Genovese G,Tonna SJ,Knob AU,Appel GB,Katz A,Bernhardy AJ,Needham AW,Lazarus R,Pollak MR

    更新日期:2010-10-01 00:00:00

  • Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats.

    abstract::Kidney disease is associated with increased cardiovascular morbidity, but underlying mechanisms are poorly understood. We tested the hypothesis that chronic renal insufficiency impairs angioadaptation in a rat model of hindlimb ischemia. Twenty male Sprague-Dawley rats (8 weeks old) underwent subtotal nephrectomy (5/6...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/sj.ki.5000448

    authors: Jacobi J,Porst M,Cordasic N,Namer B,Schmieder RE,Eckardt KU,Hilgers KF

    更新日期:2006-06-01 00:00:00

  • Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.

    abstract::Mutations in the inverted formin 2 gene (INF2) have recently been identified as the most common cause of autosomal dominant focal and segmental glomerulosclerosis (FSGS). To quantify the contribution of various genes contributing to FSGS, we sequenced INF2 where all mutations have previously been described (exons 2 to...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2012.349

    authors: Barua M,Brown EJ,Charoonratana VT,Genovese G,Sun H,Pollak MR

    更新日期:2013-02-01 00:00:00

  • Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.

    abstract:BACKGROUND:Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a potent scavenger of free radicals and has the antioxidant ability to inhibit lipid peroxidation. Its protective effect on brain ischemia has been shown. This study aimed to elucidate its possible therapeutic effects on renal oxidative stress in a rat ische...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1111/j.1523-1755.2004.00567.x

    authors: Doi K,Suzuki Y,Nakao A,Fujita T,Noiri E

    更新日期:2004-05-01 00:00:00

  • Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease.

    abstract:BACKGROUND:Fabry disease is an X-linked generalized progressive debilitating lysosomal storage disorder. The disease usually manifests in childhood, but the diagnosis is often made following the occurrence of late-stage complications such as progressive kidney failure. In order to identify key novel renal diagnostic im...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1111/j.1523-1755.2004.00846.x

    authors: Ries M,Bettis KE,Choyke P,Kopp JB,Austin HA 3rd,Brady RO,Schiffmann R

    更新日期:2004-09-01 00:00:00

  • Serum oxalate microassay using chemiluminescence detection.

    abstract::Determination of serum oxalate concentration is important for the diagnosis and monitoring of hyperoxalurias, and extends to patients with all types of renal disease. Approximately 5 to 10 ml of blood is required for each test by conventional methods, and the test is not adapted for use in children. We developed a hig...

    journal_title:Kidney international

    pub_type:

    doi:10.1038/ki.1997.505

    authors: Gaulier JM,Cochat P,Lardet G,Vallon JJ

    更新日期:1997-12-01 00:00:00

  • Role of cGMP as second messenger of adenosine in the inhibition of renin release.

    abstract::Adenosine is known to be a potent inhibitor of renin release from the kidneys. The aim of this study was to investigate the transmembrane signalling avenue that the second messenger of adenosine causes inhibition of renal renin release. Using short term cultures of juxtaglomerular cells isolated from rat kidneys, we f...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1988.70

    authors: Kurtz A,Della Bruna R,Pfeilschifter J,Bauer C

    更新日期:1988-04-01 00:00:00

  • Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.

    abstract::The Diabetes Control and Complications Trial (DCCT) has demonstrated that intensive diabetes treatment delays the onset and slows the progression of retinopathy, nephropathy, and neuropathy in patients with IDDM. A detailed description of the effects of this treatment on diabetic nephropathy is presented here. In the ...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1038/ki.1995.236

    authors:

    更新日期:1995-06-01 00:00:00

  • Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.

    abstract::Management of idiopathic glomerular disease associated with nephrotic syndrome (INS) remains controversial and one of the most complex areas relates to utilization of the drug cyclosporin. This is despite its demonstrated effectiveness in several histologic types of the INS in randomized controlled trials. Cyclosporin...

    journal_title:Kidney international

    pub_type: 共识发展会议,杂志文章

    doi:10.1038/sj.ki.5002553

    authors: Cattran DC,Alexopoulos E,Heering P,Hoyer PF,Johnston A,Meyrier A,Ponticelli C,Saito T,Choukroun G,Nachman P,Praga M,Yoshikawa N

    更新日期:2007-12-01 00:00:00

  • B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.

    abstract::We explored how B-lymphocytes influence in vitro T-cell alloresponses in patients with antibody-mediated rejection (AMR), testing whether B-cells would be preferentially involved in this group of patients. Peripheral blood mononuclear cells were collected from 65 patients having biopsy: 14 patients with AMR and 5 with...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2015.100

    authors: Shiu KY,McLaughlin L,Rebollo-Mesa I,Zhao J,Semik V,Cook HT,Roufosse C,Brookes P,Bowers RW,Galliford J,Taube D,Lechler RI,Hernandez-Fuentes MP,Dorling A

    更新日期:2015-09-01 00:00:00

  • Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells.

    abstract:BACKGROUND:Cellular and molecular mechanisms responsible for cisplatin-induced nephrotoxicity to renal tubular epithelial cells are not well understood. Although caspases play a critical role in the execution of the cell death pathway, their specific role in toxic injury to renal tubular epithelial cells has not been e...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2001.00026.x

    authors: Kaushal GP,Kaushal V,Hong X,Shah SV

    更新日期:2001-11-01 00:00:00

  • Effects of rhGH and rhIGF-1 on renal growth and morphology.

    abstract::It is known that in rodents recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor (rhIGF-1) increase renal mass. It is uncertain, however, whether renal mass increases in proportion to body growth, or whether renal growth is stimulated selectively. In 120 to 150 g female Sprague-Dawl...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1993.376

    authors: Mehls O,Irzynjec T,Ritz E,Eden S,Kovàcs G,Klaus G,Floege J,Mall G

    更新日期:1993-12-01 00:00:00

  • Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease.

    abstract::Insulin resistance from chronic kidney disease (CKD) stimulates muscle protein wasting but mechanisms causing this resistance are controversial. To help resolve this, we used microarray analyses to identify initiators of insulin resistance in the muscles of mice with CKD, glucose intolerance, and insulin resistance. C...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2013.97

    authors: Thomas SS,Dong Y,Zhang L,Mitch WE

    更新日期:2013-08-01 00:00:00

  • Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.

    abstract::Although angiotensin-converting enzyme (ACE) inhibitors are well-established drugs in the treatment of hypertension, they are not supposed to be sufficient in the inhibition of aldosterone formation. The present study analyzes the effect of aldosterone receptor antagonist, spironolactone and ACE inhibitor, captopril o...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/sj.ki.5001513

    authors: Pechanova O,Matuskova J,Capikova D,Jendekova L,Paulis L,Simko F

    更新日期:2006-07-01 00:00:00

  • The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins.

    abstract::Because of high risk of cardiovascular disease, patients with chronic kidney disease may benefit from cholesterol-lowering therapy beyond statins. A cost-effectiveness analysis of adding ezetimibe to high-dose statins for primary cardiovascular disease prevention in patients with non-dialysis-dependent chronic kidney ...

    journal_title:Kidney international

    pub_type: 评论,杂志文章

    doi:10.1016/j.kint.2019.02.029

    authors: Walther CP,Erickson KF

    更新日期:2019-07-01 00:00:00

  • New mouse model for polycystic kidney disease with both recessive and dominant gene effects.

    abstract::In the course of studying the genetics of chlorambucil mutagenesis, we have uncovered a new model for autosomal polycystic kidney disease (PKD). In the homozygous condition, the gene, jcpk, causes a very severe disease characterized by cysts in all segments of the nephron. Death usually occurs before 10 days of age. E...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1995.69

    authors: Flaherty L,Bryda EC,Collins D,Rudofsky U,Montogomery JC

    更新日期:1995-02-01 00:00:00

  • Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatment.

    abstract::To investigate the cause and the mechanisms responsible of the compulsive thirst and excessive fluid intake observed in many patients on chronic dialysis treatment, we measured plasma antidiuretic hormone (ADH), angiotensin II (Ang II) and some hemodynamic parameters in seven polydipsic and in six normodipsic patients...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1993.219

    authors: Graziani G,Badalamenti S,Del Bo A,Marabini M,Gazzano G,Como G,Viganò E,Ambroso G,Morganti A

    更新日期:1993-07-01 00:00:00

  • De novo pyrimidine nucleotide biosynthesis in isolated rat glomeruli.

    abstract::Uracil ribonucleotide-sugars and aminosugars are required for glomerular basement membrane (GBM) biosynthesis. Since these nucleotides are metabolic derivatives of uridine 5'-triphosphate (UTP), we have studied the cellular pools of uridine 5'-diphosphoglucose (UDPG), uridine 5'-diphosphoglucuronic acid (UDPGA), uridi...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.1986.146

    authors: Cortes P,Dumler F,Levin NW

    更新日期:1986-07-01 00:00:00

  • Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.

    abstract:BACKGROUND:Low urinary pH is the commonest and by far the most important factor in uric acid nephrolithiasis but the reason(s) for this defect is (are) unknown. Patients with uric acid nephrolithaisis have normal acid-base parameters according conventional clinical tests. METHODS:We studied steady-state plasma and uri...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2002.00508.x

    authors: Sakhaee K,Adams-Huet B,Moe OW,Pak CY

    更新日期:2002-09-01 00:00:00

  • Induction of stress response proteins and experimental renal ischemia/reperfusion.

    abstract:BACKGROUND:The induction of stress response (heat shock) proteins (HSPs) is a highly conserved response that protects many cell types from diverse physiological and environmental stressors. We tested the hypothesis that the induction of HSPs is protective in experimental renal ischemia/reperfusion injury. METHODS:The ...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1046/j.1523-1755.2001.0590051798.x

    authors: Kelly KJ,Baird NR,Greene AL

    更新日期:2001-05-01 00:00:00

  • Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.

    abstract:BACKGROUND:The relationship between blood pressure (BP) and mortality in hemodialysis patients has remained controversial. Some studies suggested that a lower pre- or postdialysis BP was associated with excess mortality, while others showed poorer outcome in patients with uncontrolled hypertension. We conducted a multi...

    journal_title:Kidney international

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1523-1755.2004.00812.x

    authors: Shoji T,Tsubakihara Y,Fujii M,Imai E

    更新日期:2004-09-01 00:00:00

  • Renoprotective effects of vitamin D analogs.

    abstract::Recent decades have witnessed the revelation of expanding roles of the vitamin D endocrine system beyond calcium and phosphorus metabolism. Along with these non-calcemic or non-classic actions of vitamin D are newly discovered therapeutic actions of vitamin D analogs in a number of pathological conditions, including k...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/ki.2009.175

    authors: Li YC

    更新日期:2010-07-01 00:00:00

  • Phenylalanine metabolism in uremic and normal man.

    abstract::The metabolism of phenylalanine and tyrosine was evaluated in six normal men, five chronically uremic men, and three men undergoing maintenance hemodialysis. Phenylalanine, tyrosine, and 13 acidic metabolites of those amino acids were measured in plasma postabsorptively and in plasma and urine after a phenylalanine lo...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章

    doi:10.1038/ki.1978.104

    authors: Jones MR,Kopple JD,Swendseid ME

    更新日期:1978-08-01 00:00:00

  • Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

    abstract::Recent evidence suggesting a strong interplay between components of the renin-angiotensin system and key mediators of fibrosis led us to hypothesize that renin, independent of its enzymatic action to enhance angiotensin (Ang) II synthesis, directly increases production of the fibrogenic cytokine transforming growth fa...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1038/sj.ki.5000011

    authors: Huang Y,Wongamorntham S,Kasting J,McQuillan D,Owens RT,Yu L,Noble NA,Border W

    更新日期:2006-01-01 00:00:00

  • Ultrasound dilution evaluation of pediatric hemodialysis vascular access.

    abstract:BACKGROUND:Hemodialysis access thrombosis is a significant cause of morbidity for hemodialysis patients and results from decreased access flow caused by venous outflow tract stenosis. Ultrasound dilution (UD) is a practical, noninvasive, and reliable indicator of access flow and is effective in predicting venous stenos...

    journal_title:Kidney international

    pub_type: 临床试验,杂志文章

    doi:10.1046/j.1523-1755.2001.00753.x

    authors: Goldstein SL,Allsteadt A

    更新日期:2001-06-01 00:00:00

  • Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis.

    abstract::Protein-bound uremic toxins (PBUTs) accumulate in chronic kidney disease (CKD) and are poorly removed by dialysis. Gryp et al. demonstrated that fecal bacteria from patients with CKD do not produce more PBUTs than do those from healthy controls and that the accumulation of PBUTs, as CKD progresses, is mainly due to th...

    journal_title:Kidney international

    pub_type: 杂志文章

    doi:10.1016/j.kint.2020.02.026

    authors: Jourde-Chiche N,Burtey S

    更新日期:2020-06-01 00:00:00

  • High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation.

    abstract::We evaluated short- and long-term effects of high-dose recombinant human erythropoietin (rHuEPO) in kidney transplantation in a prospective double-blind, placebo-controlled study. Patients with chronic kidney disease following receipt of a deceased donor kidney allograft were randomized to 3 doses of 40,000 units rHuE...

    journal_title:Kidney international

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/ki.2011.349

    authors: Hafer C,Becker T,Kielstein JT,Bahlmann E,Schwarz A,Grinzoff N,Drzymala D,Bonnard I,Richter N,Lehner F,Klempnauer J,Haller H,Traeder J,Fliser D

    更新日期:2012-02-01 00:00:00